EP3095797
ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.2.2013EP published:
20.5.2020EP application number:
16164567.6
EPO information:
European Patent Register
Max expiry date:
21.2.2033
Title:
ANTI DLL3 ANTIBODIES AND METHODS OF USE THEREOF
Timeline
Today
22.2.2013EP application
20.5.2020EP Publication
Owner
Name:
AbbVie Stemcentrx LLCAddress:
1 North Waukegan Road, North Chicago, IL 60064-6400, US
Inventor
Name:
STULL, Robert, A.Address:
Alameda, CA 94501, US
Name:
SAUNDERS, LauraAddress:
San Francisco, CA 94107, US
Name:
DYLLA, Scott, J.Address:
Mountain View, CA 94043, US
Name:
FOORD, OritAddress:
Foster City, CA 94404, US
Name:
LIU, DavidAddress:
San Francisco, CA 94112, US
Name:
TORGOV, MichaelAddress:
Los Angeles, CA 90045-2227, US
Name:
SHAO, HuiAddress:
Foster City, CA 94404, US
Priority
Number:
201261603173 PDate:
24.2.2012Country:
US
Number:
201261719803 PDate:
29.10.2012Country:
US
Classification
Categories:
C07K 16/28, C07K 16/30, C07K 14/47, A61P 35/00